NO20053799L - Blanding innbefattende blanding av aktive bestanddeler og en fremgangsmate ved fremstilling derav - Google Patents

Blanding innbefattende blanding av aktive bestanddeler og en fremgangsmate ved fremstilling derav

Info

Publication number
NO20053799L
NO20053799L NO20053799A NO20053799A NO20053799L NO 20053799 L NO20053799 L NO 20053799L NO 20053799 A NO20053799 A NO 20053799A NO 20053799 A NO20053799 A NO 20053799A NO 20053799 L NO20053799 L NO 20053799L
Authority
NO
Norway
Prior art keywords
mixture
preparation
active ingredients
mixing active
active ingredient
Prior art date
Application number
NO20053799A
Other languages
English (en)
Other versions
NO341294B1 (no
Inventor
Philippe Chenevier
Dominique Marechal
Original Assignee
Ethypharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm Sa filed Critical Ethypharm Sa
Publication of NO20053799L publication Critical patent/NO20053799L/no
Publication of NO341294B1 publication Critical patent/NO341294B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/003—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic followed by coating of the granules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y10T428/2998—Coated including synthetic resin or polymer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Det er beskrevet aktive bestanddelsbaserte belagte partikler hvor både kjemen og belegget inneholder aktiv bestanddel, hvor kjemen inneholder en første aktiv bestanddel mens belegget inneholder en andre aktiv bestanddel, som er forskjellig av natur.
NO20053799A 2003-02-05 2005-08-11 Blanding innbefattende blanding av aktive bestanddeler og en fremgangsmåte ved fremstilling derav NO341294B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0301308A FR2850576B1 (fr) 2003-02-05 2003-02-05 Composition comprenant un melange de principes actifs, et procede de preparation
US44719803P 2003-02-13 2003-02-13
PCT/EP2004/050035 WO2004069135A2 (en) 2003-02-05 2004-01-21 Composition comprising a mixture of active principles, and method of preparation

Publications (2)

Publication Number Publication Date
NO20053799L true NO20053799L (no) 2005-08-11
NO341294B1 NO341294B1 (no) 2017-10-02

Family

ID=32852330

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053799A NO341294B1 (no) 2003-02-05 2005-08-11 Blanding innbefattende blanding av aktive bestanddeler og en fremgangsmåte ved fremstilling derav

Country Status (18)

Country Link
US (2) US7846460B2 (no)
EP (1) EP1589954B1 (no)
JP (1) JP4791348B2 (no)
KR (1) KR20050096963A (no)
CN (1) CN1747723B (no)
AU (1) AU2004210438B2 (no)
BR (1) BRPI0407116B1 (no)
CA (1) CA2514446C (no)
EA (1) EA010972B1 (no)
ES (1) ES2590807T3 (no)
FR (1) FR2850576B1 (no)
IL (1) IL169880A (no)
IS (1) IS7998A (no)
MX (1) MXPA05008161A (no)
NO (1) NO341294B1 (no)
NZ (1) NZ541886A (no)
PL (1) PL223347B1 (no)
WO (1) WO2004069135A2 (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201509943A (zh) 2004-03-30 2015-03-16 Euro Celtique Sa 含有小於２５ｐｐｍ１４-羥可待因酮之羥可酮鹽酸鹽之組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝
US8163114B2 (en) * 2004-04-07 2012-04-24 New Jersey Institute Of Technology Netshape manufacturing processes and compositions
EP2431089A1 (en) 2005-08-02 2012-03-21 Sol-Gel Technologies Ltd. Metal oxide coating of water insoluble ingredients
FR2897267A1 (fr) * 2006-02-16 2007-08-17 Flamel Technologies Sa Formes pharmaceutiques multimicroparticulaires pour administration per os
NZ574544A (en) * 2006-08-04 2011-12-22 Ethypharm Sa Granule and orally disintegrating tablet comprising oxycodone
HUE046441T2 (hu) * 2006-09-26 2020-02-28 Novartis Ag S1P modulátort tartalmazó gyógyászati készítmények
WO2008089774A1 (fr) * 2007-01-22 2008-07-31 Crd Saidal Formulation d'un comprime orodispersible a base de paracetamol enrobe
AU2008211554B2 (en) 2007-02-01 2013-12-19 Sol-Gel Technologies Ltd. Method for preparing particles comprising metal oxide coating and particles with metal oxide coating
JP2010517996A (ja) 2007-02-01 2010-05-27 ソル − ゲル テクノロジーズ リミテッド 過酸化物及びレチノイドを含む局所適用用組成物
WO2009084216A1 (ja) * 2007-12-27 2009-07-09 Taiho Pharmaceutical Co., Ltd. 経口粉粒状抗腫瘍剤
RU2554740C2 (ru) * 2009-05-01 2015-06-27 Апталис Фарматек, Инк. Композиции перорально распадающихся таблеток, содержащие комбинации высоко- и низкодозовых лекарственных средств
CN102526124B (zh) * 2011-01-31 2013-11-20 成都科尔医药技术有限公司 一种中药粉体及其制备方法
CN109820830A (zh) * 2012-03-02 2019-05-31 罗德兹制药股份有限公司 抗破坏性立即释放型制剂类
JP6320297B2 (ja) * 2012-09-13 2018-05-09 ライオン株式会社 発泡性口腔用組成物、発泡性口腔用固形製剤及び発泡性口腔用製品
EP2906202A4 (en) * 2012-10-15 2016-04-27 Isa Odidi ORAL DRUG RELIEF FORMULATIONS
KR101484608B1 (ko) * 2012-11-26 2015-01-22 한국과학기술연구원 Pva와 알지네이트 기반 코어-쉘 구조의 복합담체 및 그 제조방법
US9687465B2 (en) 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
ES2908958T3 (es) 2013-02-01 2022-05-04 Grace W R & Co Gel de sílice porosa como portador para tecnologías líquidas
CA3042642A1 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
CA2955229C (en) 2014-07-17 2020-03-10 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
AU2015336065A1 (en) 2014-10-20 2017-05-04 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
EP3651756B1 (en) 2017-07-12 2025-09-03 Sol-Gel Technologies Ltd. Compositions comprising encapsulated tretinoin
CN111990641A (zh) * 2020-05-06 2020-11-27 焦作百仑斯生物科技有限公司 一种解酒护肝片及施工方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000044404A (ja) * 1998-07-27 2000-02-15 Otsuka Chem Co Ltd 農業用混合粒剤
CA2259727A1 (en) * 1999-01-18 2000-07-18 Bernard Charles Sherman A two-layer pharmaceutical tablet comprising an nsaid and misoprostol
US6451342B2 (en) * 2000-05-01 2002-09-17 Aeropharm Technology Incorporated Core formulation comprised of troglitazone and a biguanide
US6296874B1 (en) * 2000-05-01 2001-10-02 Aeropharm Technology Incorporated Core formulation comprising troglitazone and abiguanide
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
FR2816507B1 (fr) * 2000-11-16 2003-02-28 Ethypharm Lab Prod Ethiques Microgranules a base de principe actif, procede de fabrication et compositons pharmaceutiques integrant lesdits microgranules
ES2380827T3 (es) * 2002-12-26 2012-05-18 Pozen, Inc. Formas de dosificación con múltiples capas que contienen naproxeno y triptanes

Also Published As

Publication number Publication date
IL169880A0 (en) 2007-07-04
JP4791348B2 (ja) 2011-10-12
IS7998A (is) 2005-08-25
NO341294B1 (no) 2017-10-02
AU2004210438B2 (en) 2007-08-16
NZ541886A (en) 2008-12-24
BRPI0407116A (pt) 2006-01-10
PL223347B1 (pl) 2016-10-31
EP1589954B1 (en) 2016-08-31
FR2850576A1 (fr) 2004-08-06
EP1589954A2 (en) 2005-11-02
WO2004069135A2 (en) 2004-08-19
US20110081389A1 (en) 2011-04-07
FR2850576B1 (fr) 2007-03-23
HK1087015A1 (zh) 2006-10-06
PL376465A1 (en) 2005-12-27
CN1747723B (zh) 2010-05-12
KR20050096963A (ko) 2005-10-06
IL169880A (en) 2013-10-31
US7846460B2 (en) 2010-12-07
AU2004210438A1 (en) 2004-08-19
EA010972B1 (ru) 2008-12-30
CA2514446A1 (en) 2004-08-19
EA200501250A1 (ru) 2006-02-24
CN1747723A (zh) 2006-03-15
ES2590807T3 (es) 2016-11-23
BRPI0407116B1 (pt) 2018-04-03
CA2514446C (en) 2012-04-10
MXPA05008161A (es) 2005-10-05
US20060134422A1 (en) 2006-06-22
WO2004069135A3 (en) 2004-10-28
JP2006516597A (ja) 2006-07-06

Similar Documents

Publication Publication Date Title
NO20053799L (no) Blanding innbefattende blanding av aktive bestanddeler og en fremgangsmate ved fremstilling derav
WO2005009381A3 (en) Immediate-release formulation of acid-labile pharmaceutical compositions
WO2005044221A3 (de) Feste wirkstoff-formulierung
WO2002058753A3 (en) Coating for implantable devices and a method of forming the same
AU2003298880A1 (en) Coating for implantable devices and a method of forming the same
WO2003075857A3 (en) Amino-methyl substituted tetracycline compounds
AU2003244632A1 (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
WO2003049702A3 (en) Vanilloid receptor ligands and their use in treatments
WO2006104894A3 (en) Coating for implantable devices and a method of forming the same
MXPA03001169A (es) Biciclo-pirazoles activos como inhibidores de quinasa, proceso para su preparacion y composiciones farmaceuticas que comprenden los mismos.
SV2002000342A (es) Inhibidor de la glucogeno fosforilasa ref. pc.10753/20151/bb
WO2003002136A3 (en) Stable formulation of modified glp-1
WO2007103557A3 (en) Coating capsules with active pharmaceutical ingredients
AU2003244649A1 (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
HUP0303735A3 (en) Pyrazole derivatives for treating hiv, pharmaceutical compositions containing them and process for their preparation
BRPI0508036A (pt) derivados fundidos de pirazola
AU2002254036A1 (en) Taste masked pharmaceutical compositions
EP1190696A3 (en) Hair cosmetic compositions and use thereof
UA86413C2 (ru) Сахарное покрытие и твердая дозированая форма, которая его содержит
WO2005027843A3 (en) Chronotherapeutic dosage forms
TW200642750A (en) Fast-release microcapsule products
WO2005097076A3 (en) Low dose pharmaceutical products
AU2002358676A1 (en) Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
AU2001276698A1 (en) Pyrazole derivatives, pest controllers containing the same as the active ingredient and process for their production
AU2002313478A1 (en) Pharmaceutical preparation containing active ingredients extracted from the plants centella asiatica, mahonia aquifolium and viola tricolor

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees